Delivery Order SPE2DB24D8002-SPE2DB25FJMQF
Award Date
10/29/24
Potential Completion Date
10/30/24
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,857.60, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support the DLA Troop Support Medical's medical supply chain operations. The contract has a period of performance through May 30, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $7,379.52 and a performance period ending on November 2, 2023. The contract is an unrestricted, non-set-aside award and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ELIQUIS 5 MG TABLET 60S. The contract, valued at $2,564.93, is a firm fixed-price delivery order with an ultimate completion date of April 26, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $3,739.66 and is for the delivery of ELIQUIS 5 MG TABLET 60S. This contract is not a set-aside. Dakota Drug, Inc. holds a large Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to provide...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,462.06 Firm Fixed Price Delivery Order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. Dakota Drug, Inc. is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $3,450.22 and a performance period ending on January 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC, which is part of the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DX15D8002|SPE2DX24F2VB1, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $6,246.23 and a period of performance through February 22, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $2,440.92 and an ultimate completion date of March 21, 2025. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. also holds a significant single-award Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,403.95, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has a performance period extending through September 29, 2023 and is a firm fixed-price contract. Dakota Drug, Inc. is a key supplier to the DLA, holding a substantial Indefinite Delivery...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ELIQUIS 5 MG TABLET 60S. The contract, valued at $4,840.03, has a period of performance through June 4, 2024. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare...